Securities Times e Company Newsmortalkombatminiarcade, Junda Shares (002865...
2024-05-19 1
Gelonghui May 8| People familiar with the matter said Pfizer has agreed to settle more than 10,000 cancer-risk lawsuits related to the now-discontinued heartburn drug Zantac. The agreements involved cases in U.S. state courts but did not fully resolve the Zantac claims faced by the company. Financial details of the transaction were not immediately released. In 2020, the U.S. Food and Drug Administration asked drug makers to remove Zantac and its generics from the market because they were found in samples of the drug.baitandtackleshopnearmeA carcinogen called NDMA was found. Thousands of lawsuits have been filed in U.S. federal and state courts against Pfizer, GlaxoSmithKline and Sanofi.
相关文章
Securities Times e Company Newsmortalkombatminiarcade, Junda Shares (002865...
2024-05-19 1
News summary Lutian Chemical Company, Ningxia Hening Chemica...
2024-05-19 2
[global Financial Comprehensive report] Hong Kong stocks have made a counte...
2024-05-19 2
In the world of stock marketsgovernorofpoker3youdagamesThe law of supply an...
2024-05-19 2
Theme: 2024 Fund High-Quality Development Conference: Hundreds of big names...
2024-05-19 2
Car asSupermarioarcademachineAn important means of transportation in our da...
2024-05-19 2
thematicbaccaratbunny: 2024 Fund High-Quality Development Conference: Hundr...
2024-05-19 2
Theme: 2024 Fund High-Quality Development Conference: Hundreds of big names...
2024-05-18 2
最新评论